Teva Pharmaceutical Industries Limited (TEVA) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-10 (expected, before the open). EPS estimate 2.16, revenue estimate 13.87B.
Over the last 12 reports the stock moved 8.3% on average (either way), rising 10 times and falling 2. EPS beat estimates 10 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-03 | 2.73 | 2.22 | +23.0% | 13.67B | 13.02B | +0.8% |
| Q2 FY2026 | 2026-07-29 | 0.06 | 0.16 | -60.7% | 12.75B | 12.14B | +11.4% |
| Q1 FY2026 | 2026-04-29 | 1.47 | 1.43 | +2.8% | 11.84B | 11.47B | +10.8% |
| Q4 FY2025 | 2026-01-28 | 2.90 | 1.98 | +46.5% | 14.59B | 13.63B | +2.1% |
| Q3 FY2025 | 2025-11-05 | 2.50 | 2.23 | +12.1% | 14.36B | 14.34B | +17.8% |
| Q2 FY2025 | 2025-07-30 | 2.24 | 2.10 | +6.7% | 14.15B | 14.47B | +0.6% |
| Q1 FY2025 | 2025-05-07 | 1.77 | 1.61 | +9.9% | 13.96B | 14.66B | +6.6% |
| Q4 FY2024 | 2025-01-29 | 2.55 | 2.43 | +4.9% | 15.21B | 14.91B | -19.6% |